Vext Science, Inc. (VEXTF) Financials

VEXTF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 117.6 million 62.9 million
Dec. 31, 2025 120.3 million 65.0 million
Sept. 30, 2025 128.1 million 59.7 million
June 30, 2025 132.9 million 61.8 million

VEXTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.2 million ?
Dec. 31, 2025 2.4 million ?
Sept. 30, 2025 136000 10000
June 30, 2025 3.4 million 17546

VEXTF Net Income

No data available :(

VEXTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.6 million 22.8 million 2.9 million
Dec. 31, 2025 5.1 million 23.5 million 4.0 million
Sept. 30, 2025 3.7 million 29.7 million 3.3 million
June 30, 2025 4.6 million 29.3 million 3.9 million

VEXTF Shares Outstanding

No data available :(

VEXTF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 414183 - 3.2 million -
Dec. 31, 2025 862930 - 6.4 million -
Sept. 30, 2025 1.1 million - 3.0 million -
June 30, 2025 780132 - 2.9 million -

VEXTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 12.0 million 10.4 million
Dec. 31, 2025 13.9 million 11.9 million
Sept. 30, 2025 12.7 million 8.7 million
June 30, 2025 13.4 million 8.5 million

VEXTF

Price: $0.19

52 week price:
0.09
0.32

Earnings Per Share: -0.07 USD

P/E Ratio: -2.57

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 47.1 million

Links: